{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T08:21:31Z","timestamp":1759134091022,"version":"3.41.2"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"1070","license":[{"start":{"date-parts":[[2017,1,3]],"date-time":"2017-01-03T00:00:00Z","timestamp":1483401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objective:<\/jats:title>\n                  <jats:p>To evaluate the effect of tumour volume regression on adaptive treatment planning, reduction in doses to organs at risk (OARs) and dose escalation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods:<\/jats:title>\n                  <jats:p>20 patients undergoing radical chemoradiotherapy were imaged in the fifth week of radiotherapy (CT_45) to evaluate differences in tumour volume regression between concurrent and sequential chemoradiotherapy. Replanning was carried out in the CT_45 in those with &amp;gt;20% regression (n\u2009=\u200910) and evaluated for change in target coverage indices (the coverage index and external volume index) and doses to the OAR [mean lung dose, V \u00a020 and V \u00a05 of whole and ipsilateral lung (MLDWL, V \u00a020WL, V \u00a05WL, MLDIL, V \u00a020IL, V \u00a05IL); mean oesophagus dose, V \u00a050oesophagus; and maximum spinal cord doses]. The feasibility of maximum dose escalation was explored keeping the limit of the OAR below their tolerance limits.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>Tumour regression was higher with concurrent chemoradiotherapy as compared with sequential chemoradiotherapy (p\u2009=\u20090.02). With the adaptive plan, the mean coverage index improved from 0.96 (\u00b10.14) to 1.29 (\u00b10.36), the mean external volume index changed from 1.39(\u00b10.60) to 1.41(\u00b10.56) and the reduction in doses to the OARs were MLDWL 10.6%, V \u00a020WL 1.3%, V \u00a05WL 1.2%, MLDIL 6.6%, V \u00a020IL 1.5%, V \u00a05IL 2.3%, mean oesophagus dose 7%, V \u00a050oesophagus 31% and maximum cord dose 0.35%. Dose escalation was possible in four patients in CT_45.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion:<\/jats:title>\n                  <jats:p>There is 35% reduction in tumour volume with chemoradiotherapy at 45\u2009Gy which allows improvement in conformality, reduction in doses to the OARs and dose escalation in 40% of patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Advances in knowledge:<\/jats:title>\n                  <jats:p>This article emphasizes that adaptive planning with a single diagnostic scan at 45\u2009Gy has the potential for improvement of radiotherapy planning indices, dose escalation while respecting the dose to the OAR. This simple strategy can be helpful in radiotherapy planning upto 60\u2009Gy in 40% of the patients of locally advanced non-small-cell lung cancer in countries with limited resources.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1259\/bjr.20140234","type":"journal-article","created":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T11:33:52Z","timestamp":1480419232000},"source":"Crossref","is-referenced-by-count":7,"title":["Potential for adaptive dose escalation in radiotherapy for patients with locally advanced non-small-cell lung cancer in a low mid income setting"],"prefix":"10.1093","volume":"90","author":[{"given":"Sushma","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil K","family":"Maurya","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,1,3]]},"reference":[{"key":"2024050213543174000_b1","doi-asserted-by":"crossref","first-page":"243S","DOI":"10.1378\/chest.07-1379","article-title":"Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition)","volume":"132","author":"Robinson","year":"2007","journal-title":"Chest"},{"key":"2024050213543174000_b2","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1200\/JCO.2002.03.055","article-title":"Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019","volume":"20","author":"Albain","year":"2002","journal-title":"J Clin Oncol"},{"key":"2024050213543174000_b3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/01.coc.0000256691.27796.24","article-title":"A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer","volume":"30","author":"Yuan","year":"2007","journal-title":"Am J Clin Oncol"},{"key":"2024050213543174000_b4","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.ijrobp.2004.07.665","article-title":"Four-dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer","volume":"60","author":"Underberg","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050213543174000_b5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.radonc.2008.02.008","article-title":"Analysis of reproducibility of respiration-triggered gated radiotherapy for lung tumors","volume":"87","author":"Spoelstra","year":"2008","journal-title":"Radiother Oncol"},{"key":"2024050213543174000_b6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF03178368","article-title":"Potential radiotherapy improvements with respiratory gating","volume":"25","author":"Keall","year":"2002","journal-title":"Australas Phys Eng Sci Med"},{"key":"2024050213543174000_b7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1748-717X-1-8","article-title":"A dosimetric analysis of respiration-gated radiotherapy in patients with stage III lung cancer","volume":"1","author":"Underberg","year":"2006","journal-title":"Radiat Oncol"},{"key":"2024050213543174000_b8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ijrobp.2005.07.957","article-title":"Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer","volume":"64","author":"Hansen","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050213543174000_b9","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.ijrobp.2006.11.018","article-title":"Is adaptive treatment planning required for stereotactic radiotherapy of stage I non-small-cell lung cancer?","volume":"67","author":"Haasbeek","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050213543174000_b10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00066-015-0927-y","article-title":"Cone-beam CT-guided radiotherapy in the management of lung cancer: diagnostic and therapeutic value","volume":"192","author":"Elsayad","year":"2016","journal-title":"Strahlenther Onkol"},{"key":"2024050213543174000_b11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","article-title":"Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"},{"key":"2024050213543174000_b12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijrobp.2014.09.033","article-title":"Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small-cell lung cancer beneficial? A multi-institutional propensity score matched analysis","volume":"91","author":"Rodrigues","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050213543174000_b13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4103\/2278-330X.119893","article-title":"Challenges in optimizing chemoradiation in locally advanced non small-cell lung cancers in India","volume":"2","author":"Agrawal","year":"2013","journal-title":"South Asian J Cancer"},{"key":"2024050213543174000_b14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fonc.2014.00237","article-title":"Human resources for cancer control in uttar pradesh, India: a case study for low and middle income countries","volume":"4","author":"Daphtary","year":"2014","journal-title":"Front Oncol"},{"volume-title":"ICRU report 62: Prescribing, recording, and reporting photon beam therapy (supplement to ICRU report 50)","year":"1999","author":"International Commission on Radiation Units and Measurements","key":"2024050213543174000_b15"},{"key":"2024050213543174000_b16","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.ijrobp.2005.04.046","article-title":"Serial megavoltage CT imaging during external beam radiotherapy for non-small-cell lung cancer: observations on tumor regression during treatment","volume":"63","author":"Kupelian","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050213543174000_b17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijrobp.2006.03.064","article-title":"Tumor volume changes on serial imaging with megavoltage CT for non-small-cell lung cancer during intensity-modulated radiotherapy: how reliable, consistent, and meaningful is the effect?","volume":"66","author":"Siker","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050213543174000_b18","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.ijrobp.2010.04.002","article-title":"Daily megavoltage computed tomography in lung cancer radiotherapy: correlation between volumetric changes and local outcome","volume":"80","author":"Bral","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050213543174000_b19","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.ijrobp.2010.04.050","article-title":"Potential of adaptive radiotherapy to escalate the radiation dose in combined radiochemotherapy for locally advanced non-small cell lung cancer","volume":"79","author":"Guckenberger","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050213543174000_b20","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.ijrobp.2007.07.2369","article-title":"Adaptive radiotherapy planning on decreasing gross tumor volumes as seen on megavoltage computed tomography images","volume":"69","author":"Woodford","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050213543174000_b21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.radonc.2008.05.004","article-title":"Additional PET\/CT in week 5\u20136 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?","volume":"88","author":"Gillham","year":"2008","journal-title":"Radiother Oncol"},{"key":"2024050213543174000_b22","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ijrobp.2007.08.078","article-title":"Dosimetric advantages of four-dimensional adaptive image-guided radiotherapy for lung tumors using online cone-beam computed tomography","volume":"70","author":"Harsolia","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050213543174000_b23","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1016\/j.ijrobp.2011.01.067","article-title":"Adaptive radiotherapy for locally advanced non-small-cell lung cancer does not underdose the microscopic disease and has the potential to increase tumor control","volume":"81","author":"Guckenberger","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050213543174000_b24","first-page":"1S","article-title":"A tabulated summary of the FDG PET literature","volume":"42","author":"Gambhir","year":"2001","journal-title":"J Nucl Med"},{"key":"2024050213543174000_b25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijrobp.2003.10.044","article-title":"Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer","volume":"59","author":"Bradley","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050213543174000_b26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0167-8140(01)00470-4","article-title":"Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET)","volume":"62","author":"Erdi","year":"2002","journal-title":"Radiother Oncol"},{"key":"2024050213543174000_b27","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ijrobp.2008.10.054","article-title":"Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing","volume":"73","author":"Feng","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050213543174000_b28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.prro.2015.02.012","article-title":"Definitive radiation therapy in locally advanced non-small cell lung cancer: executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline","volume":"5","author":"Rodrigues","year":"2015","journal-title":"Pract Radiat Oncol"}],"container-title":["The British Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/90\/1070\/20140234\/57383613\/bjr.20140234.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/90\/1070\/20140234\/57383613\/bjr.20140234.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T14:01:06Z","timestamp":1714658466000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjr\/article\/doi\/10.1259\/bjr.20140234\/7446025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,3]]},"references-count":28,"journal-issue":{"issue":"1070","published-online":{"date-parts":[[2017,1,3]]},"published-print":{"date-parts":[[2017,2,1]]}},"URL":"https:\/\/doi.org\/10.1259\/bjr.20140234","relation":{},"ISSN":["0007-1285","1748-880X"],"issn-type":[{"type":"print","value":"0007-1285"},{"type":"electronic","value":"1748-880X"}],"subject":[],"published-other":{"date-parts":[[2017,2,1]]},"published":{"date-parts":[[2017,1,3]]},"article-number":"20140234"}}